Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06215404

Fluid Management Strategies on Blood Loss in Liver Transplantation

Effects of Different Fluid Management Strategies on Blood Loss, Inflammatory Response, and Major Organ Sequelae in Liver Transplantation

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
National Taiwan University Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

During liver transplantation, due to the complexity of the operation and abnormal coagulation function, there may be a large amount of bleeding and corresponding blood transfusion. Excessive blood transfusion will increase pulmonary complications and affect the prognosis. Infusion management to reduce bleeding is a very important issue in liver transplant surgery. Restrictive infusion management can effectively reduce the amount of bleeding in liver transplantation, but it remains unclear whether it will cause sequelae in other major organs. The investigators plan to study different infusion goals and strategies in liver transplant surgery using a randomized group model, using the PiCCO (Pulse Contour Cardiac Output) cardiopulmonary volume monitor, and setting the stroke volume variation (SVV) as the macroscopic circulation.The purpose of this study was to divide it into restrictive and liberal groups to explore the impact on liver transplantation bleeding volume and inflammatory response as well as postoperative lung and renal function, and to collect statistics on clinical care and postoperative sequelae (pulmonary liver, renal function impairment, etc.) in order to develop the most appropriate infusion management strategy in liver transplantation.

Conditions

Interventions

TypeNameDescription
OTHERLiberal groupFluid challage to keep stroke volume variation \< 10%
OTHERrestrictive groupFluid challage to keep stroke volume variation \< 18%

Timeline

Start date
2024-01-15
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2024-01-22
Last updated
2025-04-11

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT06215404. Inclusion in this directory is not an endorsement.